Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TraMel-WT: Trametinib in Advanced BRAF Wild-type Melanoma
NCT04059224Phase 2Completed
- Sponsor
- UZ Brussel
- Start
- Jan 2019
- Primary completion
- Jun 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of trametinib in melanoma, sponsored by UZ Brussel. Started Jan 2019; status: completed.
02
Drugs
trametinib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT04059224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04059224.